Companies: 10,795·Total market cap: $144.5T
Akero Therapeutics, Inc.

Akero Therapeutics, Inc.

AKRONASDAQHealthcare
$54.65
+$0.00(+0.00%)
Market Cap$4.5B
P/E Ratio
52W High$58.4
52W Low$21.34
Overview

Akero Therapeutics, Inc. (AKRO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AKRO · as of Feb 28, 2025

Latest filing snapshot

63
+8+14.55%vs prior year

Akero Therapeutics, Inc. (AKRO) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
63
Change (1Y)
+8
Growth % (1Y)
+14.55%
Revenue / Employee
Net Income / Employee
$-4.00M
Market Cap
$4.5B

AKRO Employee Count

2019 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-02-2863+8+14.55%
2024-02-2955+17+44.74%
2023-03-1738+5+15.15%
2022-02-2533+12+57.14%
2021-03-1621+8+61.54%
2020-03-1613

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
ACADIA Pharmaceuticals Inc.
ACAD
ACADIA Pharmaceuticals Inc.
653
#2
Crinetics Pharmaceuticals, Inc.
CRNX
Crinetics Pharmaceuticals, Inc.
437
#3
Immunovant, Inc.
IMVT
Immunovant, Inc.
362
#4
Kymera Therapeutics, Inc.
KYMR
Kymera Therapeutics, Inc.
208
#5
Arcellx, Inc.
ACLX
Arcellx, Inc.
163
#6
Centessa Pharmaceuticals plc
CNTA
Centessa Pharmaceuticals plc
77
#7
Akero Therapeutics, Inc.
AKRO
Akero Therapeutics, Inc.YOU
63
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AKRO peer comparison

About AKRO employees

AKRO Employees · Headcount

Akero Therapeutics, Inc. (AKRO) employee data is sourced from the annual SEC 10-K filing. As of 2024, Akero Therapeutics, Inc. had 63 full-time employees globally. Full-time employees only. Global consolidated headcount.

Akero Therapeutics, Inc.'s workforce increased by 8 (14.55%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

AKRO Employees · 5 questions

As of the latest SEC 10-K filing (2024), Akero Therapeutics, Inc. had 63 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Akero Therapeutics, Inc. employee counthow many employees does Akero Therapeutics, Inc. haveAKRO total employees 2024

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-02-28